期刊文献+

联合过继免疫细胞输注小鼠后DC、NK分布的研究 被引量:2

The Localization of Natural Killer Cells and Dendritic Cells in Murine Transplanted Tumor after Joint Adoptive-Immunity Cell Infusion
下载PDF
导出
摘要 目的:观察自然杀伤(NK)细胞/树突状细胞(DC)联合过继免疫治疗小鼠皮下黑色素瘤时效应细胞在荷瘤小鼠体内的分布。方法:建立C57BL/6小鼠皮下黑色素瘤模型,体外培养增殖小鼠NK细胞、DC并标记,以不同比例混合两种细胞,分别以静脉注射和瘤内注射的方式回输荷瘤小鼠体内,于注射后不同时间点取肿瘤、肝、脾、肺组织进行切片,观察各组织中效应细胞的数量及分布。结果:静脉注射组NK细胞、DC主要分布在肿瘤微循环及实质组织中,各时间点NK细胞、DC的浸润数量有显著差异(P<0.01),注射后4h浸润的效应细胞最多,12h最少,在脾脏中见少量NK细胞的分布,在肝脏及肺组织中偶见。瘤内注射组NK细胞、DC主要分布在肿瘤实质组织中,各观察时间点NK细胞、DC的浸润数量有显著差异(P<0.01),注射后1h浸润的效应细胞最多,12h最少,在肝、脾、肺组织中未见NK细胞、DC分布。两种注射方式下按不同比例混合进行NK细胞、DC的过继治疗,各组间差异具有显著性(P<0.01),混合注射组效应细胞在肿瘤组织内的浸润多于单独注射组。结论:NK细胞、DC免疫过继后能够“靶向性”聚集在肿瘤周围及肿瘤内部,对肿瘤具有治疗作用,NK细胞、DC联合过继免疫治疗效果优于单独注射,提示NK细胞、DC联合输注可能成为肿瘤生物治疗的新模式。 Objective: To study the localization of effector adoptively transferred natural killer (NK) cells and dendritic cells (DCs) in murine subcutaneously tumor. Methods: B16-F10 melanoma cell line was implanted subcutaneously into C57BL/6 mice. NK cells and DCs were prepared and labeled with Brdu and DAPI. The mice received labeled NK cells and DCs via the vein or located injection. Tumor and other organs were removed at different time points after the adoptive transfer and processed. The histopathological change of tumors were observed by HE staining. The labeled NK cells and DCs were obsevered and numbered by use of fluorescense microscope. Results: NK cells and DCs adopted by. the vein injection accumulated mostly in tumors and microcirculation of tumor, and the number of effector cells was significantly different (P〈0.01). By four hours after injection, significantly more cells were seen in the tumor compared with other time points, and by 12 hours after injection, that was the least. As in the cases of adoptived by localized injection, infiltrative NK cells and DCs localized in the tumors. And the number of the effective cells in different time points was significantly different (P〈0.01). It was the highest in one hour and the lowest in twelve hours after injection. There was a significantly difference (P〈0.01) as adopting different cells, and the number of received NK cells combined with DCs was higher than injection of single kind of cells. Conclusions: NK cells and DCs are accumulated in tumor and those lead to the necrosis or apoptosis of the tumors.NK cells combined with DC are effective immunotherapy in tumor of mouse.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2006年第5期270-273,共4页 Chinese Journal of Clinical Oncology
基金 黑龙江省科技攻关重点基金项目资助(编号:GB05C401-03)
关键词 杀伤细胞 天然 树突细胞 过继转移 免疫 肿瘤 Killer cell Nature Dendritic cell Immune Adoptive transfer Tumor
  • 相关文献

参考文献8

  • 1Andrews DM,Scalzo AA,Yokoyama WM,et al.Functional interactions between dendritic cells and NK cells during viral infection[J].Nat Immunol,2003,4(2):175~181.
  • 2Buentke E,D'Amato M,Scheynius A.Malassezia enhances natural killer cell-induced dendritic cell maturation[J].Scand J Immunol,2004,59(5):511~516.
  • 3Piccioli D,Sbrana S,Melandri E,et al.Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells[J].J Exp Med,2002,195(3):335~341.
  • 4Moretta L,Ferlazzo G,Mingari MC,et al.Human natural killer cell function and their interactions with dendritic cells[J].Vaccine,2003,21(2):38~42.
  • 5Cooper MA,Bush JE,Fehniger TA,et al.In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells[J].Blood,2002,100(10):3633~3638.
  • 6Fehniger TA,Cooper MA,Nuovo GJ,et al.CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2:a potential new link between adaptive and innate immunity[J].Blood,2003,101(8):3052~3057.
  • 7Zitvogel L.Dendritic and natural killer cells cooperate in the control/switch of innate immunity[J].J Exp Med,2002,195(3):9~14.
  • 8Yang Q,Hokland ME,Bryant JL,et al.Tumor-localization by adoptively transferred,interleukin-2-activated NK cells leads to destruction of well-established lung metastases[J].Int J Cancer,2003,105(4):512~519.

同被引文献29

  • 1朱挺,张乐鸣,周建良,柯孔亮.大肠癌hTERT、SYK分子边界的临床研究[J].肿瘤研究与临床,2008,20(10):682-684. 被引量:1
  • 2刘京龙,邓志华.端粒酶在肿瘤基因治疗方面的研究进展[J].肿瘤研究与临床,2008,20(10):713-715. 被引量:3
  • 3陈纲,凌斌,祝怀平,赵卫东,王群华,张红雁,吴爱东,魏海明,田志刚.自然杀伤细胞系NK-92治疗卵巢癌的体外及动物实验研究[J].中华妇产科杂志,2005,40(7):476-479. 被引量:10
  • 4Belgiovine C, Chiodi I, Mondello C. Telomerase: cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex[J]. Cytogenet Genome Res, 2008, 122: 255-262.
  • 5Majerska J, Sykorova E, Fajkus J. Non-telomeric activities of telomerase[J]. Mol Biosyst, 2011, 7: 1013-1023.
  • 6Cao X, Kong CM, Mathi KM, et al. The use of transformed IMR90 cell model to identify the potential extra-telomeric effects of hTERT in cell migration and DNA damage response[J]. BMC Biochem, 2014, 15: 17.
  • 7Lamy E, Goetz V, Erlacher M, et al. hTERT: Another brick in the wall of cancer cells[J]. Mutat Res, 2013, 752:119-128.
  • 8Qin Y, Guo H, Tang B, et al. The non-reverse transcriptase activity of the human telomerase reverse transcriptase promotes tumor progression (review)[J]. Int J Oncol, 2014, 45: 525-531.
  • 9Niu BL, Du HM, Shen HP, et al. Myeloid dendritic cells loaded with dendritic tandem multiple antigenic telomerase reverse transcriptase (hTERT) epitope peptides: a potentially promising tumor vaccine[J]. Vaccine, 2012, 30: 3395-404.
  • 10Gerosa F, Baldani-Guerra B, Nisii C, et al. Reciprocal activating interaction between natural killer cells and dendritic cells [J]. J Exp Med, 2002, 195: 327-333.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部